Related Experiment Video
Updated: Jul 19, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Genetic background determines response to hemostasis and thrombosis
Jane Hoover-Plow1, Aleksey Shchurin, Erika Hart
1Department of Cardiovascular Medicine, Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Ohio, USA. hooverj@ccf.org
Genetic background significantly impacts thrombosis and hemostasis. A/J mice show increased rebleeding compared to C57BL/6J mice, with specific chromosomes influencing this phenotype.
Area of Science:
- Cardiovascular Biology
- Genetics
- Hemostasis and Thrombosis
Background:
- Thrombosis is a major cause of cardiovascular disease mortality.
- C57BL/6J and A/J mice exhibit distinct differences in cardiovascular phenotypes.
- The influence of genetic background on thrombosis and hemostasis pathways is not fully understood.
Purpose of the Study:
- To investigate thrombosis and hemostasis differences between C57BL/6J and A/J mice.
- To identify genetic loci controlling these phenotypes using chromosome substitution strains.
Main Methods:
- Ferric chloride-induced carotid artery thrombosis model to measure occlusion time.
- Tail bleeding and rebleeding assays as hemostasis markers.
- Screening of 21 A/J chromosome substitution strains on a C57BL/6J background.
Main Results:
- A/J mice exhibited decreased thrombus occlusion time and increased rebleeding time compared to C57BL/6J mice.
- Tail collagen content was higher in A/J mice.
- Three chromosome substitution strains (B6-Chr5A/J, B6-Chr11A/J, B6-Chr17A/J) showed increased rebleeding, similar to A/J mice.
Conclusions:
- Genetic background significantly influences arterial thrombosis and hemostasis.
- Specific A/J chromosomes (5 and 17) contribute to increased rebleeding.
- Identifying genetic determinants of thrombotic risk is feasible through these models.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
08:30Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Principles of Pharmacogenetics: Types of Genetic Variants